Capital Advisors Ltd’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Capital Advisors Ltd’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-777	Closed	-$1K	–	1713
2024 Q1	$1K	Buy	+777	New	+$1.15K	﹤0.01%	1319
2023 Q4	–	Sell	-630	Closed	-$1K	–	1536
2023 Q3	$1K	Buy	+630	New	+$1.3K	﹤0.01%	1251

Capital Advisors Ltd's NGM Position: Q2 2024 in Review

Capital Advisors Ltd sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 777 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in NGM in Q3 2023 and held it in 2 quarters. The position peaked at $1K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Capital Advisors Ltd reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Capital Advisors Ltd sold 777 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1K.
Capital Advisors Ltd first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Capital Advisors Ltd's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1K in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Capital Advisors Ltd's 13F filing for Q2 2024, filed 25 Jul 2024.